Literature DB >> 30411806

Diagnostic Performance and Accuracy of the 3 Interpreting Methods of Breast Strain Elastography: A Systematic Review and Meta-analysis.

Richard G Barr1,2,3,4,5, Annalisa De Silvestri6,3,4,5, Valeria Scotti7,3,4,5, Federica Manzoni6,3,4,5, Chiara Rebuffi7,3,4,5, Cristina Capittini6,3,4,5, Carmine Tinelli6,3,4,5.   

Abstract

There are 3 methods of interpreting breast strain elastography: the elastographic-to-B-mode length ratio (E/B), a 5-point color scale (5P), and the strain ratio (SR). This meta-analysis assessed which method is superior to the others. A systematic search of the medical literature was performed in July 2017. Studies were eligible for inclusion if they fulfilled the following criteria: (1) had biopsy-proven or long-term stability as the reference standard; (2) used either the E/B, 5P, or SR to interpret results; and (3) had at least 50 cases. A total of 220 records were retrieved; 60 full-text articles were examined, and 46 were included in the meta-analysis. Publication years ranged from 2007 and 2017. The quality of studies was generally high. The mean age of women was 48 years; 12,398 lesions (4242 malignant) were analyzed. For the 5P method, the sensitivity was 77%; specificity, 87%; positive likelihood ratio (LR), 5.3; and negative LR, 0.24. For the SR method, sensitivity was 87%; specificity, 81%; positive LR, 4.8; and negative LR, 0.16. For the E/B method, sensitivity was 96%; specificity, 88%; positive LR, 7.1; and negative LR, 0.03. Of the 3 methods, the E/B had the highest sensitivity, and the E/B and 5P had the highest specificity. With a negative LR of 0.03, the E/B method can downgrade lesions with a pretest probability of 50% to a 2% probability of malignancy.
© 2018 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  breast; breast cancer; breast tumors; elastography; sonoelastography

Year:  2018        PMID: 30411806     DOI: 10.1002/jum.14849

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  7 in total

Review 1.  BI-RADS 3 on Screening Breast Ultrasound: What Is It and What Is the Appropriate Management?

Authors:  Wendie A Berg
Journal:  J Breast Imaging       Date:  2021-08-15

2.  Deep Learning-Based Radiomics of B-Mode Ultrasonography and Shear-Wave Elastography: Improved Performance in Breast Mass Classification.

Authors:  Xiang Zhang; Ming Liang; Zehong Yang; Chushan Zheng; Jiayi Wu; Bing Ou; Haojiang Li; Xiaoyan Wu; Baoming Luo; Jun Shen
Journal:  Front Oncol       Date:  2020-08-28       Impact factor: 6.244

3.  Modeling Uncertainty of Strain Ratio Measurements in Ultrasound Breast Strain Elastography: A Factorial Experiment.

Authors:  David Rosen; Jingfeng Jiang
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2019-09-23       Impact factor: 2.725

4.  The significance of dual-mode elastography in the diagnosis of breast lesions by physicians with different levels of experience.

Authors:  Sijing Huang; Xiuqin Ye; Keen Yang; Hongtian Tian; Zhimin Ding; Jing Chen; Jinfeng Xu; Fajin Dong
Journal:  Quant Imaging Med Surg       Date:  2022-02

5.  Diagnostic and Predictive Values of Strain Ratios in the Regions of Interests in Reference Tissue for Breast Tumor.

Authors:  Hui Wang; Cui-Ying Li; Hai-Ling Zha; Di Xu; Zhi-Bin Hu
Journal:  Cancer Manag Res       Date:  2021-02-04       Impact factor: 3.989

6.  Hybrid high-definition microvessel imaging/shear wave elastography improves breast lesion characterization.

Authors:  Juanjuan Gu; Redouane Ternifi; Mostafa Fatemi; Azra Alizad; Nicholas B Larson; Jodi M Carter; Judy C Boughey; Daniela L Stan; Robert T Fazzio
Journal:  Breast Cancer Res       Date:  2022-03-05       Impact factor: 8.408

Review 7.  Breast Tumour Classification Using Ultrasound Elastography with Machine Learning: A Systematic Scoping Review.

Authors:  Ye-Jiao Mao; Hyo-Jung Lim; Ming Ni; Wai-Hin Yan; Duo Wai-Chi Wong; James Chung-Wai Cheung
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.